The store will not work correctly when cookies are disabled.
2,4-dichloro-N-(1-ethylpiperidin-4-yl)benzamide
ID: ALA4101561
PubChem CID: 17174058
Max Phase: Preclinical
Molecular Formula: C14H18Cl2N2O
Molecular Weight: 301.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CCC(NC(=O)c2ccc(Cl)cc2Cl)CC1
Standard InChI: InChI=1S/C14H18Cl2N2O/c1-2-18-7-5-11(6-8-18)17-14(19)12-4-3-10(15)9-13(12)16/h3-4,9,11H,2,5-8H2,1H3,(H,17,19)
Standard InChI Key: IFLSLVGASJBYBN-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
32.8926 -7.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8915 -8.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5995 -9.2188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3092 -8.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3063 -7.9867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5977 -7.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5953 -6.7642 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
32.1834 -9.2178 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.0125 -7.5754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7217 -7.9813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0094 -6.7582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.4279 -7.5701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1357 -7.9787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8398 -7.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8409 -6.7534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1319 -6.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4216 -6.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5487 -6.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2564 -6.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
2 8 1 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 301.22 | Molecular Weight (Monoisotopic): 300.0796 | AlogP: 3.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 8.79 | CX LogP: 2.64 | CX LogD: 1.24 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.93 | Np Likeness Score: -2.02 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |